Clinical efficiency of 50 g oral glucose challenge test, 75 g and 100 g oral glucose tolerance test for screening and diagnosis of gestational diabetes.
- Author:
Se Na PARK
1
;
Young Ju CHA
;
Kyung Ah JEONG
;
Eun Hee YOO
;
Shun Hee CHUN
;
Chong Il KIM
Author Information
1. Department of Obstetrics and Gynecology, School of Medicine, Ewha Womans University, Seoul, Korea. ogjeong@ewha.ac.kr
- Publication Type:Original Article
- Keywords:
Gestational diabetes mellitus;
50 g;
75 g;
100 g oral glucose challenge test
- MeSH:
Diabetes, Gestational;
Female;
Glucose;
Glucose Tolerance Test;
Humans;
Pregnancy;
Pregnant Women;
Retrospective Studies
- From:Korean Journal of Perinatology
2008;19(2):131-141
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The purpose of this study was to compare the clinical efficiency of 75 g oral glucose tolerance test (OGTT) with those of 100 g OGTT for diagnosing gestational diabetes mellitus (GDM) after abnormal 50 g oral glucose challenge test (OGCT). METHODS: Data of 616 pregnant women delivered at Ewha Womans University Dongdaemoon hospital from January, 2003 to June, 2007 was reviewed and analyzed retrospectively. The positive diagnostic rate of GDM for the group resulted in the range of 130 and 140 mg/dl and in 140 mg/dl and higher on the 50 g OGCT group was analyzed. Pregnancy and fetal outcomes were compared for the women who showed positive results in the 75 g and 100 g OGTT. RESULTS: Of the 28 pregnant women whose results were in the range of 130 and 140 mg/dL on the 50 g OGCT, three women (10.7%) were diagnosed as GDM. Among women who showed the results of 140 mg/dL and higher, positive rate of GDM by 75 g OGTT (51.6%) was significantly higher than those by 100 g OGTT (31.6%) (p=0.047). The positive result group of 75 g and 100 g OGTT did not show significant differences in pregnancy and fetal outcomes except that BMI of 100 g OGTT positive group was more increased at early pregnancy (25.2+/-3.53 kg/m2 vs 22.9+/-3.26 kg/m2, p=0.043). CONCLUSION: 75 g OGTT may be a more convenient and useful tool in the diagnosis of GDM to protect for adverse outcomes in untreated gravidas with minimal hyperglycemia.
